Véronique Laithier

2.7k total citations
27 papers, 1.1k citations indexed

About

Véronique Laithier is a scholar working on Oncology, Molecular Biology and Hepatology. According to data from OpenAlex, Véronique Laithier has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Hepatology. Recurrent topics in Véronique Laithier's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Neuroblastoma Research and Treatments (5 papers) and Lung Cancer Research Studies (5 papers). Véronique Laithier is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Neuroblastoma Research and Treatments (5 papers) and Lung Cancer Research Studies (5 papers). Véronique Laithier collaborates with scholars based in France, Switzerland and Italy. Véronique Laithier's co-authors include Giorgio Perilongo, Derek Roebuck, Piotr Czauderna, Margaret Childs, Rudolf Maibach, Daniël C. Aronson, Penelope Brock, József Zsíros, Laurence Brugières and Arthur Zimmermann and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Véronique Laithier

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Véronique Laithier France 12 524 370 313 271 267 27 1.1k
Danuta Perek Poland 17 145 0.3× 249 0.7× 167 0.5× 213 0.8× 432 1.6× 56 1.1k
P Ardouin France 13 107 0.2× 277 0.7× 93 0.3× 107 0.4× 268 1.0× 19 799
Angela D. Trobaugh‐Lotrario United States 14 181 0.3× 142 0.4× 146 0.5× 70 0.3× 209 0.8× 22 524
Makoto Shibuya Japan 15 48 0.1× 316 0.9× 334 1.1× 99 0.4× 251 0.9× 34 774
Gudrun Zulehner Austria 15 143 0.3× 272 0.7× 52 0.2× 180 0.7× 409 1.5× 46 946
Pellegrino Crafa Italy 21 41 0.1× 686 1.9× 354 1.1× 126 0.5× 253 0.9× 70 1.2k
Noboru Nagahara Japan 15 73 0.1× 137 0.4× 149 0.5× 769 2.8× 437 1.6× 21 1.0k
T. Strohmeyer Germany 17 68 0.1× 249 0.7× 418 1.3× 66 0.2× 437 1.6× 41 979
Zhendong Chen China 13 331 0.6× 383 1.0× 100 0.3× 13 0.0× 160 0.6× 28 783
Gidi Rechavi Israel 17 38 0.1× 265 0.7× 92 0.3× 71 0.3× 614 2.3× 26 1.1k

Countries citing papers authored by Véronique Laithier

Since Specialization
Citations

This map shows the geographic impact of Véronique Laithier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Laithier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Laithier more than expected).

Fields of papers citing papers by Véronique Laithier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Laithier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Laithier. The network helps show where Véronique Laithier may publish in the future.

Co-authorship network of co-authors of Véronique Laithier

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Laithier. A scholar is included among the top collaborators of Véronique Laithier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Laithier. Véronique Laithier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirsch, Théo Z., Dominique Vidaud, Véronique Laithier, et al.. (2025). Hepatoblastoma in a patient with neurofibromatosis type 1: A case report. Cancer Genetics. 292-293. 35–37. 1 indexed citations
2.
Taque, Sophie, Véronique Laithier, Hélène Sudour‐Bonnange, et al.. (2021). Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies. Hepatology International. 16(1). 125–134. 7 indexed citations
3.
Pariente, Danièle, Sophie Taque, Sophie Branchereau, et al.. (2020). Tumor rupture in hepatoblastoma: A high risk factor?. Pediatric Blood & Cancer. 67(9). e28549–e28549. 8 indexed citations
4.
6.
Zsíros, József, Laurence Brugières, Penelope Brock, et al.. (2013). Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. The Lancet Oncology. 14(9). 834–842. 217 indexed citations
7.
Semeraro, Michaëla, Sophie Branchereau, Rudolf Maibach, et al.. (2012). Relapses in hepatoblastoma patients: Clinical characteristics and outcome – Experience of the International Childhood Liver Tumour Strategy Group (SIOPEL). European Journal of Cancer. 49(4). 915–922. 75 indexed citations
8.
Brugières, Laurence, Sophie Branchereau, & Véronique Laithier. (2012). Tumeurs malignes primitives du foie de l’enfant. Bulletin du Cancer. 99(2). 219–228. 6 indexed citations
9.
Casanova, Michela, Penelope Brock, Laurence Brugières, et al.. (2011). DOSE DENSE CISPLATIN IMPROVES SURVIVAL IN CHILDREN PRESENTING WITH METASTATIC HEPATOBLASTOMA : LESSONS FROM SIOPEL 1 TO 4. 57(5). 724–725. 1 indexed citations
10.
Haas, Válerie de, Jacques Grill, Marie‐Anne Raquin, et al.. (2009). Relapses of optic pathway tumors after first‐line chemotherapy. Pediatric Blood & Cancer. 52(5). 575–580. 16 indexed citations
11.
Perilongo, Giorgio, Rudolf Maibach, Laurence Brugières, et al.. (2009). Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma. New England Journal of Medicine. 361(17). 1662–1670. 205 indexed citations
12.
Laithier, Véronique, et al.. (2006). Tumeur rhabdoïde hépatique maligne avec rupture spontanée. Annales de Pathologie. 26(2). 122–125. 6 indexed citations
13.
Laithier, Véronique, A.-M. Bertrand, B Kantelip, et al.. (2005). Goitre thyroïdien révélateur d'un lymphome non hodgkinien : à propos de 2 cas. Archives de Pédiatrie. 13(1). 38–40. 2 indexed citations
14.
Bernier‐Chastagner, Valérie, Jacques Grill, François Doz, et al.. (2005). Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas. Cancer. 104(12). 2792–2797. 60 indexed citations
15.
Contassot, Emmanuel, Christophe Ferrand, R Angonin, et al.. (2000). GANCICLOVIR-SENSITIVE ACUTE GRAFT-VERSUS-HOST DISEASE IN MICE RECEIVING HERPES SIMPLEX VIRUS-THYMIDINE KINASE???EXPRESSING DONOR T CELLS IN A BONE MARROW TRANSPLANTATION SETTING1. Transplantation. 69(4). 503–508. 26 indexed citations
16.
Contassot, Emmanuel, Éric Robinet, R Angonin, et al.. (1998). Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes. Bone Marrow Transplantation. 22(11). 1097–1102. 15 indexed citations
19.
Tiberghien, Pierre, Véronique Laithier, Mohamed Mabed, et al.. (1993). Interleukin-1 treatment before allogeneic bone marrow transplantation: pre-clinical studies.. PubMed. 35(3). 237–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026